Phathom Pharmaceuticals, Inc.
PHAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$334 | -$202 | -$198 | -$144 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $24 | $45 | $0 | $17 |
| Change in WC | -$15 | -$14 | $5 | -$27 |
| Other Non-Cash | $58 | $32 | $45 | $5 |
| Operating Cash Flow | -$267 | -$138 | -$147 | -$148 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$2 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $59 | $39 | $95 | $43 |
| Stock Issued | $122 | $155 | $25 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $173 | $0 | $2 |
| Financing Cash Flow | $183 | $368 | $120 | $45 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$84 | $228 | -$28 | -$104 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $384 | $156 | $183 | $287 |
| End Cash | $300 | $384 | $155 | $183 |
| Free Cash Flow | -$267 | -$139 | -$148 | -$149 |